Ahmed Elkhanany

Assistant Professor

Email

ahmed.elkhanany@bcm.edu

Positions

Assistant Professor: Lester & Sue Smith Breast Center
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States

Addresses

Dan L Duncan Comprehensive Cancer Center (Clinic): O’Quinn Medical Tower at Baylor St. Luke’s Medical Center’s McNair Campus
1919 Old Spanish Trail
Houston, TX, 77054
United States
Phone: (832) 957-6500
Fax: (713) 610-4595

Education

MD from Alexandria University School of Medicine: 03/2011 - Alexandria, Egypt

Residency at University of Missouri at Kansas City: 06/2016 - Kansas City, Missouri, United States; Internal Medicine

Fellowship at Roswell Park Comprehensive Cancer Center: 06/2019 - Buffalo, New York, United States; Hematology and Oncology

Postdoctoral Fellowship at Mayo Clinic: 06/2013 - Rochester, Minnesota, United States; Triple Negative Breast Cancer

Graduate Certificate at Harvard Business School: 06/2024 - Boston, Massachusetts, United States; Health Care Leadership

Certifications

Hematology and Medical Oncology: #369657; American Board of Internal Medicine

Internal Medicine: #369657; American Board of Internal Medicine

Honors & Awards

Teacher of the year Award: University of Alabama at Birmingham (06/2022)

Unsung Hero Award: University of Alabama at Birmingham (10/2021)

Fellow Champion Award: University of Alabama at Birmingham (01/2023)

Best Oncology Teacher: Recognized among division of hematology and oncology faculty for contributions in BCM fellow education and patient care.; Baylor College of Medicine (06/2024)

Best Medicine Faculty Research Mentor: Recognized among department of medicine faculty for providing mentorship, research, and career guidance to internal medicine residents at BCM.; Baylor College of Medicine (06/2025)

Arab America 40 under 40: Recognized for contributions to advance healthcare delivery to underserved population.; Arab America (07/2025)

Professional Statement

Dr. Ahmed Elkhanany is an Assistant Professor of Medicine at the Lester and Sue Smith Breast Center at Baylor College of Medicine. He is board certified in internal medicine, hematology and oncology. Dr. Elkhanany received his medical degree from the Alexandria University School of Medicine in Egypt. He completed his internal medicine residency in University of Missouri-Kansas City and his fellowship in Roswell Park Comprehensive Cancer Center. Dr. Elkhanany specializes in the care of patients with breast cancer. He also is a member of the Breast Cancer Prevention and High-Risk Clinic at Baylor College of Medicine and has a special interest in breast cancer prevention and metastatic breast cancer. Dr. Elkhanany research interests lie in translational Breast Cancer genomics and impact of race and ethnicity on gene drivers of breast cancer. He is involved with projects that translate lab-based findings to bedside novel treatment combinations in the hope of improving patient lives and finding novel less toxic cures.

Dr. Elkhanany sees breast cancer patients and high-risk breast health consults at both The O’Quinn Medical Tower at the McNair Campus and The Harris Health Smith Clinic.

Websites

Google Scholar

PubMed

VIICTR Publications List

Videos

Breast cancer rates rising in young women

FOX 26 news segment discussing rising breast cancer incidence in the United States.

Selected Publications

Daly, Mary B., et al. "Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology." Journal of the National Comprehensive Cancer Network 19.1 (2021): 77-102.. " ;
Daly, Mary B., et al. "NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines." Journal of the National Comprehensive Cancer Network 18.4 (2020): 380-391.. " ;
Yao, Song, et al. "Breast tumor microenvironment in black women: a distinct signature of CD8+ T-cell exhaustion." JNCI: Journal of the National Cancer Institute 113.8 (2021): 1036-1043.. " ;
Sinha, Sutapa, et al. "Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo." International journal of cancer 132.5 (2013): 1201-1212.. " ;
Leon-Ferre, Roberto A., et al. "Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer." Breast cancer research and treatment 167 (2018): 89-99.. " ;
Abdou, Yara, et al. "Primary and secondary breast angiosarcoma: single center report and a meta-analysis." Breast Cancer Research and Treatment 178 (2019): 523-533.. " ;
Bhattacharya, Santanu, et al. "GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways." PloS one 9.12 (2014): e114409.. " ;
Stringer-Reasor, Erica M., et al. "Disparities in breast cancer associated with African American identity." American Society of Clinical Oncology Educational Book 41 (2021): e29-e46.. " ;
Gandhi, Shipra, et al. "Contribution of immune cells to glucocorticoid receptor expression in breast cancer." International journal of molecular sciences 21.13 (2020): 4635.. " ;
Vaklavas, Christos, et al. "A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer." Breast Cancer Research and Treatment 198.2 (2023): 217-229.. " ;
Vidula, Neelima, et al. "Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer." NPJ Breast Cancer 8.1 (2022): 117.. " ;
Bartow, Brooke B., et al. "Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma." Cancers 15.9 (2023): 2524.. " ;
Blau, Sibel, et al. "Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model." JCO Clinical Cancer Informatics 7 (2023): e2200164.. " ;
Elkhanany, Ahmed, Eriko Katsuta, and Kazuaki Takabe. "Racial disparity in breast cancer immune microenvironment." (2018): 1081-1081.. " ;
Parsons, Heather A., et al. "Abstract PD11-06: PD11-06 Circulating tumor DNA association with residual cancer burden after neoadjuvant therapy in triple negative breast cancer in TBCRC 030." Cancer Research 83.5_Supplement (2023): PD11-06.. " ;
Franks, Jeffrey, et al. "Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer." Breast Cancer Research and Treatment 197.3 (2023): 673-681.. " ;

Memberships

American Society of Clinical Oncology: Member (01/2013)

European Society for Medical Oncology: Member (06/2016)

Skills

Breast Cancer: Breast Cancer diagnosis, management and treatment.

Hereditary Breast Conditions: Management of hereditary genetic predispositions for Breast Cancer.

Breast Cancer Genomics: Understanding genetic changes in breast cancer that can help pinpoint cancer weaknesses and exploit new therapy opportunities.

Breast Cancer Clinical Trials: Development of clinical trials that utilize latest findings from within the BCM college laboratories to directly translate this into novel treatments used in the clinic.

Languages

Arabic